Loading…

In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants

An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pan...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2000-02, Vol.82 (4), p.931-936
Main Authors: Van Noorden, C J F, Jonges, T G N, Meade-Tollin, L C, Smith, R E, Koehler, A
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73
cites
container_end_page 936
container_issue 4
container_start_page 931
container_title British journal of cancer
container_volume 82
creator Van Noorden, C J F
Jonges, T G N
Meade-Tollin, L C
Smith, R E
Koehler, A
description An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign
doi_str_mv 10.1054/bjoc.1999.1021
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70973301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0EokvhyhFZCHHL1h9JHF-QUNVCpUpc4Gx5ncnGq6wdbGfL_nts7YoWJE6e8Tx-Z8YvQm8pWVPS1FebnTdrKqXMKaPP0Io2nFW0Y-I5WhFCREUkIxfoVYy7nErSiZfoghLBmWi7FbJ3Dh_swWPrRruxyXqH_YDNMSawDvAcfAl0hIh7mPQx4jQC9i5CKuA2-Ic0lmhc9trhWTsTQCdrsMkhBAy_5km7FF-jF4OeIrw5n5fox-3N9-uv1f23L3fXn-8rU3csVcAIb1hr-h7ahgyaQEtZzbmhg9Cy6UUHIPuesQFYnbcwQ2tYvqdc8rofBL9En06687LZQ2_ApaAnNQe71-GovLbq74qzo9r6g2Jc1DVps8DHs0DwPxeISe1tNDDlLcAvUQkiBeeEZvD9P-DOL8Hl5RRjUnY164ra-gSZ4GMMMPyZhBJVLFTFQlUsVMXC_ODd0_mf4CfPMvDhDOho9DSE_M82PnKctU1bGl-dsJgrbgvhcbr_dP4Nps22Mw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229984286</pqid></control><display><type>article</type><title>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</title><source>PubMed Central</source><creator>Van Noorden, C J F ; Jonges, T G N ; Meade-Tollin, L C ; Smith, R E ; Koehler, A</creator><creatorcontrib>Van Noorden, C J F ; Jonges, T G N ; Meade-Tollin, L C ; Smith, R E ; Koehler, A</creatorcontrib><description>An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1054/bjoc.1999.1021</identifier><identifier>PMID: 10732768</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animal tumors. Experimental tumors ; Animals ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cell Differentiation ; Cell Division - drug effects ; Cysteine Endopeptidases - drug effects ; Cysteine Proteinase Inhibitors - pharmacology ; Drug Resistance ; Epidemiology ; Experimental tumors, general aspects ; Female ; Humans ; Medical sciences ; Mice ; Mice, Nude ; Molecular Medicine ; Oncology ; Pancreatic cancer ; Pancreatic Neoplasms - enzymology ; Pancreatic Neoplasms - pathology ; Regular ; regular-article ; Tumors</subject><ispartof>British journal of cancer, 2000-02, Vol.82 (4), p.931-936</ispartof><rights>The Author(s) 2000</rights><rights>2000 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Feb 2000</rights><rights>Copyright © 2000 Cancer Research Campaign 2000 Cancer Research Campaign</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374406/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374406/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1326566$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10732768$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Noorden, C J F</creatorcontrib><creatorcontrib>Jonges, T G N</creatorcontrib><creatorcontrib>Meade-Tollin, L C</creatorcontrib><creatorcontrib>Smith, R E</creatorcontrib><creatorcontrib>Koehler, A</creatorcontrib><title>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign</description><subject>Animal tumors. Experimental tumors</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cell Differentiation</subject><subject>Cell Division - drug effects</subject><subject>Cysteine Endopeptidases - drug effects</subject><subject>Cysteine Proteinase Inhibitors - pharmacology</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Experimental tumors, general aspects</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - enzymology</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Regular</subject><subject>regular-article</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNp1kU1v1DAQhi0EokvhyhFZCHHL1h9JHF-QUNVCpUpc4Gx5ncnGq6wdbGfL_nts7YoWJE6e8Tx-Z8YvQm8pWVPS1FebnTdrKqXMKaPP0Io2nFW0Y-I5WhFCREUkIxfoVYy7nErSiZfoghLBmWi7FbJ3Dh_swWPrRruxyXqH_YDNMSawDvAcfAl0hIh7mPQx4jQC9i5CKuA2-Ic0lmhc9trhWTsTQCdrsMkhBAy_5km7FF-jF4OeIrw5n5fox-3N9-uv1f23L3fXn-8rU3csVcAIb1hr-h7ahgyaQEtZzbmhg9Cy6UUHIPuesQFYnbcwQ2tYvqdc8rofBL9En06687LZQ2_ApaAnNQe71-GovLbq74qzo9r6g2Jc1DVps8DHs0DwPxeISe1tNDDlLcAvUQkiBeeEZvD9P-DOL8Hl5RRjUnY164ra-gSZ4GMMMPyZhBJVLFTFQlUsVMXC_ODd0_mf4CfPMvDhDOho9DSE_M82PnKctU1bGl-dsJgrbgvhcbr_dP4Nps22Mw</recordid><startdate>20000201</startdate><enddate>20000201</enddate><creator>Van Noorden, C J F</creator><creator>Jonges, T G N</creator><creator>Meade-Tollin, L C</creator><creator>Smith, R E</creator><creator>Koehler, A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20000201</creationdate><title>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</title><author>Van Noorden, C J F ; Jonges, T G N ; Meade-Tollin, L C ; Smith, R E ; Koehler, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animal tumors. Experimental tumors</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cell Differentiation</topic><topic>Cell Division - drug effects</topic><topic>Cysteine Endopeptidases - drug effects</topic><topic>Cysteine Proteinase Inhibitors - pharmacology</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Experimental tumors, general aspects</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - enzymology</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Regular</topic><topic>regular-article</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Noorden, C J F</creatorcontrib><creatorcontrib>Jonges, T G N</creatorcontrib><creatorcontrib>Meade-Tollin, L C</creatorcontrib><creatorcontrib>Smith, R E</creatorcontrib><creatorcontrib>Koehler, A</creatorcontrib><collection>SpringerOpen</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Noorden, C J F</au><au>Jonges, T G N</au><au>Meade-Tollin, L C</au><au>Smith, R E</au><au>Koehler, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2000-02-01</date><risdate>2000</risdate><volume>82</volume><issue>4</issue><spage>931</spage><epage>936</epage><pages>931-936</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>10732768</pmid><doi>10.1054/bjoc.1999.1021</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2000-02, Vol.82 (4), p.931-936
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374406
source PubMed Central
subjects Animal tumors. Experimental tumors
Animals
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cell Differentiation
Cell Division - drug effects
Cysteine Endopeptidases - drug effects
Cysteine Proteinase Inhibitors - pharmacology
Drug Resistance
Epidemiology
Experimental tumors, general aspects
Female
Humans
Medical sciences
Mice
Mice, Nude
Molecular Medicine
Oncology
Pancreatic cancer
Pancreatic Neoplasms - enzymology
Pancreatic Neoplasms - pathology
Regular
regular-article
Tumors
title In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A48%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20inhibition%20of%20cysteine%20proteinases%20delays%20the%20onset%20of%20growth%20of%20human%20pancreatic%20cancer%20explants&rft.jtitle=British%20journal%20of%20cancer&rft.au=Van%20Noorden,%20C%20J%20F&rft.date=2000-02-01&rft.volume=82&rft.issue=4&rft.spage=931&rft.epage=936&rft.pages=931-936&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1054/bjoc.1999.1021&rft_dat=%3Cproquest_pubme%3E70973301%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=229984286&rft_id=info:pmid/10732768&rfr_iscdi=true